Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Alena Jirásková"'
Publikováno v:
International Journal of Molecular Sciences, Vol 24, Iss 13, p 10614 (2023)
Bilirubin has potent biological beneficial effects, protecting against atherosclerosis, obesity, and metabolic syndrome. The aim of this study was to assess serum bilirubin concentrations and (TA)n and (GT)n microsatellite variations in the promoter
Externí odkaz:
https://doaj.org/article/1f66eec237b84abc9c3fec0b383d600d
Autor:
Libor Vítek, Alena Jirásková, Ivana Malíková, Gabriela Dostálová, Lenka Eremiášová, Vilém Danzig, Aleš Linhart, Martin Haluzík
Publikováno v:
Antioxidants, Vol 11, Iss 11, p 2118 (2022)
Oxidative stress and inflammation contribute significantly to atherogenesis. We and others have demonstrated that mildly elevated serum bilirubin levels protect against coronary and peripheral atherosclerosis, most likely due to the antioxidant and a
Externí odkaz:
https://doaj.org/article/2a210b659d3c492b9bfbf1e44abfcd14
Autor:
Jaromír Petrtýl, Karel Dvořák, Jan Stříteský, Martin Leníček, Alena Jirásková, Václav Šmíd, Martin Haluzík, Radan Brůha, Libor Vítek
Publikováno v:
Antioxidants, Vol 10, Iss 12, p 2000 (2021)
Non-alcoholic fatty liver disease (NAFLD) is the most prevalent chronic liver disorder worldwide. The aim of our study was to assess the role of bilirubin, and the heme oxygenase 1 (HMOX1) and bilirubin UDP-glucuronosyl transferase (UGT1A1) promoter
Externí odkaz:
https://doaj.org/article/033bb2e8916540f4bfa7ade8cf3b9de0
Publikováno v:
International Journal of Molecular Sciences; Volume 24; Issue 13; Pages: 10614
Bilirubin has potent biological beneficial effects, protecting against atherosclerosis, obesity, and metabolic syndrome. The aim of this study was to assess serum bilirubin concentrations and (TA)n and (GT)n microsatellite variations in the promoter
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=multidiscipl::f01bb4e64fa81f7780047d96608acd25
Autor:
Vítek, Jaromír Petrtýl, Karel Dvořák, Jan Stříteský, Martin Leníček, Alena Jirásková, Václav Šmíd, Martin Haluzík, Radan Brůha, Libor
Publikováno v:
Antioxidants; Volume 10; Issue 12; Pages: 2000
Non-alcoholic fatty liver disease (NAFLD) is the most prevalent chronic liver disorder worldwide. The aim of our study was to assess the role of bilirubin, and the heme oxygenase 1 (HMOX1) and bilirubin UDP-glucuronosyl transferase (UGT1A1) promoter
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=multidiscipl::09b979ec07ff6f893bcd1159fd4a8fcd
Autor:
Alena, Jirásková, Giulia, Bortolussi, Gabriela, Dostálová, Lenka, Eremiášová, Lubor, Golaň, Vilém, Danzig, Aleš, Linhart, Libor, Vítek
Publikováno v:
Oxidative Medicine and Cellular Longevity
The aim of our study was to assess the possible relationships among heme oxygenase (HMOX), bilirubin UDP-glucuronosyl transferase (UGT1A1) promoter gene variations, serum bilirubin levels, and Fabry disease (FD). The study included 56 patients with F
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::cf7717e5b44973c3f6dc9a6a66e0b3d5
https://pubmed.ncbi.nlm.nih.gov/28951772
https://pubmed.ncbi.nlm.nih.gov/28951772